Skip to main content
Walter Noordzij
dr.

In my profession as a nuclear medicine physician, I’m involved in both clinical and scientific applications of nuclear medicine and radiology modalities. My main interests include haematology, general oncology, radio-immunotherapy, and especially the implementation of new therapeutic strategies. Currently, I have a special interest in imaging post-transplant lymphoproliferative disease, as well as radio-immunotherapy in chemotherapy refractory (non)-Hodgkin’s lymphoma.

Effects of dose heterogeneity on response and toxicity after 90Y-SIRT for HCC
Published in: European Journal of Nuclear Medicine and Molecular Imaging
PURPOSE: Yttrium-90 (90Y) selective internal radiation therapy (SIRT) is an established treatment for hepatocellular carcinoma (HCC), yet dose-response relationships remain incompletely understood. We evaluated whether voxel-based dose heterogeneity is associated with tumour response and treatment-related toxicity. METHODS: This retrospective study included 45 HCC patients with 68 lesions treated with 90Y resin SIRT. Dose distributions were derived from post-therapy 90Y PET/CT. DVH-based metrics included hot-spot (D2, D10, Dmax), cold-spot (D90, D98, Dmin), and coverage parameters (V100, V150, V200). Tumour response was assessed using mRECIST. Grade ≥ 3 toxicity was classified as...
Terbium-161 might be superior to lutetium-177 for oligometastases – Authors’ reply
Published in: The Lancet Oncology
Bastiaan M. Privé, Walter Noordzij, Steffie Peters, Bart J.R. Timmermans, Alexis Vrachimis, Daniela E. Oprea-Lager, James Nagarajah
Diagnostic accuracy of PSMA-targeted radioguided surgery in prostate cancer at multiple anatomical levels: a systematic review and meta-analysis
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Background: Prostate-specific membrane antigen (PSMA)-targeted radioguided surgery (PSMA-RGS) is a promising intraoperative technique for improving lesion localization and surgical accuracy in prostate cancer (PCa), particularly in high-risk or recurrent cases. Objective: To systematically evaluate the diagnostic performance of PSMA-RGS in PCa using multilevel meta-analysis. Methods: Following PRISMA 2020 guidelines, we searched PubMed, Embase, and Web of Science for clinical studies published between January 2016 and May 2025, with the final search performed on May 1, 2025, and identified 28 eligible studies. Diagnostic accuracy was assessed at the patient,...
Fang Wen, Laura Schäfer, Xinlin Zheng, Hao Huang, Walter Noordzij, Matthias Saar, Felix M Mottaghy, Susanne Lütje
Standardizing PSMA PET/CT reporting in prostate cancer: from structured frameworks to AI-assisted interpretation
Published in: Abdominal Radiology
PSMA PET/CT is increasingly used for prostate cancer staging, restaging, treatment selection, and therapy response assessment. In parallel, several interpretation frameworks have been developed to standardize reporting. PROMISE version 2 integrates the PRIMARY score for local disease, molecular imaging TNM staging, and a PSMA expression score. PSMA-RADS 2.0 supports lesion-level characterization, whereas response systems such as the PSMA PET progression criteria and RECIP 1.0 focus on treatment response assessment. Despite the availability of these systems and professional society guidance, real-world reporting remains heterogeneous, with limited framework adoption, inconsistent...
Yuki Arita, Xinlin Zheng, Fang Wen, Motohiro Fujiwara, Moniba Bijari, Andor W.J.M. Glaudemans, Simeon J.S. Ruiter, Susanne Lütje, Walter Noordzij
Clinical assessment before PET/computed tomography: frequency and diagnostic impact
Published in: Nuclear Medicine Communications
Objective – To investigate how often referring physicians perform history taking and physical examination before PET/computed tomography (PET/CT) referral, and whether their absence influences clinical reasoning quality or diagnostic yield.  Methods – Patients undergoing PET/CT at a tertiary academic hospital were asked whether their referring physician had conducted history taking and physical examination before referral. Associations between omission of clinical assessment and clinical reasoning quality or PET/CT positivity (defined as PET/CT findings relevant to the clinical indication) were analyzed using multivariable regression.  Results – Among 288 patients (median...
Mohammed A.M. Alqahtani, Yuki Arita, Walter Noordzij, Thomas C. Kwee